Carlee Moser Selected Research

Carlee Moser Research Topics

Disease

22	COVID-19 05/2024 - 09/2021
7	Inflammation (Inflammations) 01/2023 - 08/2015
6	Acquired Immunodeficiency Syndrome (AIDS) 01/2023 - 09/2016
5	Insulin Resistance 01/2022 - 09/2016
3	Infections 10/2023 - 10/2021
2	Myocardial Infarction 10/2020 - 01/2019
2	HIV Infections (HIV Infection) 01/2017 - 01/2016
1	Disease Progression 05/2024
1	Viremia 01/2023
1	Glucose Intolerance 01/2022
1	Weight Gain 01/2022
1	Body Weight (Weight, Body) 12/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021
1	Stroke (Strokes) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Atherosclerosis 01/2017
1	Parkinson Disease (Parkinson's Disease) 01/2012

Drug/Important Bio-Agent (IBA)

10	Monoclonal AntibodiesIBA 05/2024 - 12/2021
8	Antiviral Agents (Antivirals)IBA 05/2024 - 08/2015
7	bamlanivimabIBA 11/2023 - 09/2021
7	RNA (Ribonucleic Acid)IBA 10/2023 - 01/2021
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 08/2015
4	C-Reactive ProteinIBA 01/2022 - 08/2015
3	ruxolitinibIBA 01/2023 - 12/2021
3	AdiponectinIBA 01/2022 - 01/2021
3	Raltegravir Potassium FDA Link 01/2022 - 08/2015
3	LeptinIBA 01/2022 - 01/2021
3	Interleukin-6 (Interleukin 6)IBA 12/2021 - 08/2015
2	romlusevimabIBA 05/2024 - 01/2023
2	amubarvimabIBA 05/2024 - 01/2023
2	Viral RNAIBA 10/2023 - 08/2022
2	nirmatrelvir and ritonavir drug combinationIBA 01/2023 - 08/2022
2	Immunoglobulin G (IgG)IBA 01/2023 - 12/2022
2	Atazanavir Sulfate (Reyataz)FDA Link 01/2022 - 08/2015
2	Darunavir (Prezista)FDA Link 01/2022 - 08/2015
2	Ritonavir (Norvir)FDA Link 01/2022 - 08/2015
2	LipidsIBA 01/2022 - 01/2021
2	Tenofovir (Viread)FDA Link 01/2022 - 09/2016
2	Emtricitabine (Emtriva)FDA Link 01/2022 - 09/2016
2	Lipopolysaccharide ReceptorsIBA 12/2021 - 08/2015
2	HDL LipoproteinsIBA 01/2021 - 01/2017
2	Protease Inhibitors (Protease Inhibitor)IBA 09/2016 - 08/2015
1	EpitopesIBA 11/2023
1	Messenger RNA (mRNA)IBA 11/2023
1	Therapeutic UsesIBA 11/2023
1	Neutralizing AntibodiesIBA 10/2023
1	camostatIBA 10/2023
1	VaccinesIBA 01/2023
1	Sirolimus (Rapamycin)FDA Link 01/2023
1	Immunoglobulins (Immunoglobulin)IBA 01/2023
1	SAB-185IBA 01/2023
1	tixagevimabIBA 01/2023
1	cilgavimabIBA 01/2023
1	Janus Kinase InhibitorsIBA 01/2022
1	AdipokinesIBA 01/2022
1	AntigensIBA 12/2021
1	Nucleic AcidsIBA 12/2021
1	CytokinesIBA 12/2021
1	Cytochrome P-450 CYP3AIBA 12/2021
1	efavirenz (Sustiva)FDA Link 12/2021
1	Janus Kinase 1IBA 12/2021
1	Advanced Glycation End ProductsIBA 10/2021
1	HDL CholesterolIBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2021
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2021
1	lipopolysaccharide-binding proteinIBA 10/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Lipoproteins (Lipoprotein)IBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 09/2016
1	fibrin fragment D (D-dimer)IBA 08/2015
1	Integrase InhibitorsIBA 08/2015
1	SynucleinsIBA 01/2012

Therapy/Procedure

13	Therapeutics 11/2023 - 08/2015
5	Art Therapy 01/2019 - 08/2015
1	Investigational Therapies (Experimental Therapy) 11/2022